IBDEI0QB ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26461,2)
 ;;=^5003792
 ;;^UTILITY(U,$J,358.3,26462,0)
 ;;=G25.71^^100^1273^14
 ;;^UTILITY(U,$J,358.3,26462,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26462,1,3,0)
 ;;=3^Tardive Akathisia
 ;;^UTILITY(U,$J,358.3,26462,1,4,0)
 ;;=4^G25.71
 ;;^UTILITY(U,$J,358.3,26462,2)
 ;;=^5003799
 ;;^UTILITY(U,$J,358.3,26463,0)
 ;;=G25.79^^100^1273^9
 ;;^UTILITY(U,$J,358.3,26463,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26463,1,3,0)
 ;;=3^Medication-Induced Movement Disorder,Other
 ;;^UTILITY(U,$J,358.3,26463,1,4,0)
 ;;=4^G25.79
 ;;^UTILITY(U,$J,358.3,26463,2)
 ;;=^5003800
 ;;^UTILITY(U,$J,358.3,26464,0)
 ;;=T43.205A^^100^1273^4
 ;;^UTILITY(U,$J,358.3,26464,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26464,1,3,0)
 ;;=3^Antidepressant Discontinuation Syndrome,Init Encntr
 ;;^UTILITY(U,$J,358.3,26464,1,4,0)
 ;;=4^T43.205A
 ;;^UTILITY(U,$J,358.3,26464,2)
 ;;=^5050540
 ;;^UTILITY(U,$J,358.3,26465,0)
 ;;=T43.205D^^100^1273^5
 ;;^UTILITY(U,$J,358.3,26465,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26465,1,3,0)
 ;;=3^Antidepressant Discontinuation Syndrome,Subseq Encntr
 ;;^UTILITY(U,$J,358.3,26465,1,4,0)
 ;;=4^T43.205D
 ;;^UTILITY(U,$J,358.3,26465,2)
 ;;=^5050541
 ;;^UTILITY(U,$J,358.3,26466,0)
 ;;=T43.205S^^100^1273^6
 ;;^UTILITY(U,$J,358.3,26466,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26466,1,3,0)
 ;;=3^Antidepressant Discontinuation Syndrome,Sequela
 ;;^UTILITY(U,$J,358.3,26466,1,4,0)
 ;;=4^T43.205S
 ;;^UTILITY(U,$J,358.3,26466,2)
 ;;=^5050542
 ;;^UTILITY(U,$J,358.3,26467,0)
 ;;=G25.71^^100^1273^7
 ;;^UTILITY(U,$J,358.3,26467,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26467,1,3,0)
 ;;=3^Medication-Induced Acute Akathisia
 ;;^UTILITY(U,$J,358.3,26467,1,4,0)
 ;;=4^G25.71
 ;;^UTILITY(U,$J,358.3,26467,2)
 ;;=^5003799
 ;;^UTILITY(U,$J,358.3,26468,0)
 ;;=G24.02^^100^1273^8
 ;;^UTILITY(U,$J,358.3,26468,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26468,1,3,0)
 ;;=3^Medication-Induced Acute Dystonia
 ;;^UTILITY(U,$J,358.3,26468,1,4,0)
 ;;=4^G24.02
 ;;^UTILITY(U,$J,358.3,26468,2)
 ;;=^5003785
 ;;^UTILITY(U,$J,358.3,26469,0)
 ;;=G21.0^^100^1273^12
 ;;^UTILITY(U,$J,358.3,26469,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26469,1,3,0)
 ;;=3^Neuroleptic Malignant Syndrome
 ;;^UTILITY(U,$J,358.3,26469,1,4,0)
 ;;=4^G21.0
 ;;^UTILITY(U,$J,358.3,26469,2)
 ;;=^5003771
 ;;^UTILITY(U,$J,358.3,26470,0)
 ;;=T50.905A^^100^1273^1
 ;;^UTILITY(U,$J,358.3,26470,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26470,1,3,0)
 ;;=3^Adverse Effect of Medication,Other,Init Encntr
 ;;^UTILITY(U,$J,358.3,26470,1,4,0)
 ;;=4^T50.905A
 ;;^UTILITY(U,$J,358.3,26470,2)
 ;;=^5052160
 ;;^UTILITY(U,$J,358.3,26471,0)
 ;;=T50.905S^^100^1273^2
 ;;^UTILITY(U,$J,358.3,26471,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26471,1,3,0)
 ;;=3^Adverse Effect of Medication,Other,Sequela
 ;;^UTILITY(U,$J,358.3,26471,1,4,0)
 ;;=4^T50.905S
 ;;^UTILITY(U,$J,358.3,26471,2)
 ;;=^5052162
 ;;^UTILITY(U,$J,358.3,26472,0)
 ;;=T50.905D^^100^1273^3
 ;;^UTILITY(U,$J,358.3,26472,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26472,1,3,0)
 ;;=3^Adverse Effect of Medication,Other,Subseq Encntr
 ;;^UTILITY(U,$J,358.3,26472,1,4,0)
 ;;=4^T50.905D
 ;;^UTILITY(U,$J,358.3,26472,2)
 ;;=^5052161
 ;;^UTILITY(U,$J,358.3,26473,0)
 ;;=F42.^^100^1274^5
 ;;^UTILITY(U,$J,358.3,26473,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26473,1,3,0)
 ;;=3^Obsessive-Compulsive Disorder
 ;;^UTILITY(U,$J,358.3,26473,1,4,0)
 ;;=4^F42.
 ;;^UTILITY(U,$J,358.3,26473,2)
 ;;=^5003568
 ;;^UTILITY(U,$J,358.3,26474,0)
 ;;=F45.22^^100^1274^1
 ;;^UTILITY(U,$J,358.3,26474,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26474,1,3,0)
 ;;=3^Body Dysmorphic Disorder
 ;;^UTILITY(U,$J,358.3,26474,1,4,0)
 ;;=4^F45.22
 ;;^UTILITY(U,$J,358.3,26474,2)
 ;;=^5003588
 ;;^UTILITY(U,$J,358.3,26475,0)
 ;;=F63.3^^100^1274^6
 ;;^UTILITY(U,$J,358.3,26475,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26475,1,3,0)
 ;;=3^Trichotillomania (Hair-Pulling Disorder)
 ;;^UTILITY(U,$J,358.3,26475,1,4,0)
 ;;=4^F63.3
 ;;^UTILITY(U,$J,358.3,26475,2)
 ;;=^5003643
 ;;^UTILITY(U,$J,358.3,26476,0)
 ;;=L98.1^^100^1274^2
 ;;^UTILITY(U,$J,358.3,26476,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26476,1,3,0)
 ;;=3^Excoriation (Skin-Picking) Disorder
 ;;^UTILITY(U,$J,358.3,26476,1,4,0)
 ;;=4^L98.1
 ;;^UTILITY(U,$J,358.3,26476,2)
 ;;=^186781
 ;;^UTILITY(U,$J,358.3,26477,0)
 ;;=F42.^^100^1274^3
 ;;^UTILITY(U,$J,358.3,26477,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26477,1,3,0)
 ;;=3^Hoarding Disorder
 ;;^UTILITY(U,$J,358.3,26477,1,4,0)
 ;;=4^F42.
 ;;^UTILITY(U,$J,358.3,26477,2)
 ;;=^5003568
 ;;^UTILITY(U,$J,358.3,26478,0)
 ;;=F06.8^^100^1274^4
 ;;^UTILITY(U,$J,358.3,26478,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26478,1,3,0)
 ;;=3^Obsessive-Compulsive & Related Disorder d/t Another Med Condition
 ;;^UTILITY(U,$J,358.3,26478,1,4,0)
 ;;=4^F06.8
 ;;^UTILITY(U,$J,358.3,26478,2)
 ;;=^5003062
 ;;^UTILITY(U,$J,358.3,26479,0)
 ;;=Z91.49^^100^1275^12
 ;;^UTILITY(U,$J,358.3,26479,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26479,1,3,0)
 ;;=3^Personal Hx of Psychological Trauma
 ;;^UTILITY(U,$J,358.3,26479,1,4,0)
 ;;=4^Z91.49
 ;;^UTILITY(U,$J,358.3,26479,2)
 ;;=^5063623
 ;;^UTILITY(U,$J,358.3,26480,0)
 ;;=Z91.5^^100^1275^13
 ;;^UTILITY(U,$J,358.3,26480,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26480,1,3,0)
 ;;=3^Personal Hx of Self-Harm
 ;;^UTILITY(U,$J,358.3,26480,1,4,0)
 ;;=4^Z91.5
 ;;^UTILITY(U,$J,358.3,26480,2)
 ;;=^5063624
 ;;^UTILITY(U,$J,358.3,26481,0)
 ;;=Z91.82^^100^1275^11
 ;;^UTILITY(U,$J,358.3,26481,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26481,1,3,0)
 ;;=3^Personal Hx of Military Deployment
 ;;^UTILITY(U,$J,358.3,26481,1,4,0)
 ;;=4^Z91.82
 ;;^UTILITY(U,$J,358.3,26481,2)
 ;;=^5063626
 ;;^UTILITY(U,$J,358.3,26482,0)
 ;;=Z91.89^^100^1275^18
 ;;^UTILITY(U,$J,358.3,26482,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26482,1,3,0)
 ;;=3^Personal Risk Factors
 ;;^UTILITY(U,$J,358.3,26482,1,4,0)
 ;;=4^Z91.89
 ;;^UTILITY(U,$J,358.3,26482,2)
 ;;=^5063628
 ;;^UTILITY(U,$J,358.3,26483,0)
 ;;=Z72.9^^100^1275^19
 ;;^UTILITY(U,$J,358.3,26483,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26483,1,3,0)
 ;;=3^Problem Related to Lifestyle
 ;;^UTILITY(U,$J,358.3,26483,1,4,0)
 ;;=4^Z72.9
 ;;^UTILITY(U,$J,358.3,26483,2)
 ;;=^5063267
 ;;^UTILITY(U,$J,358.3,26484,0)
 ;;=Z72.811^^100^1275^1
 ;;^UTILITY(U,$J,358.3,26484,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26484,1,3,0)
 ;;=3^Adult Antisocial Behavior
 ;;^UTILITY(U,$J,358.3,26484,1,4,0)
 ;;=4^Z72.811
 ;;^UTILITY(U,$J,358.3,26484,2)
 ;;=^5063263
 ;;^UTILITY(U,$J,358.3,26485,0)
 ;;=Z91.19^^100^1275^5
 ;;^UTILITY(U,$J,358.3,26485,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26485,1,3,0)
 ;;=3^Nonadherence to Medical Treatment
 ;;^UTILITY(U,$J,358.3,26485,1,4,0)
 ;;=4^Z91.19
 ;;^UTILITY(U,$J,358.3,26485,2)
 ;;=^5063618
 ;;^UTILITY(U,$J,358.3,26486,0)
 ;;=E66.9^^100^1275^6
 ;;^UTILITY(U,$J,358.3,26486,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26486,1,3,0)
 ;;=3^Overweight or Obesity
 ;;^UTILITY(U,$J,358.3,26486,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,26486,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,26487,0)
 ;;=Z76.5^^100^1275^3
 ;;^UTILITY(U,$J,358.3,26487,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26487,1,3,0)
 ;;=3^Malingering
 ;;^UTILITY(U,$J,358.3,26487,1,4,0)
 ;;=4^Z76.5
 ;;^UTILITY(U,$J,358.3,26487,2)
 ;;=^5063302
 ;;^UTILITY(U,$J,358.3,26488,0)
 ;;=R41.83^^100^1275^2
 ;;^UTILITY(U,$J,358.3,26488,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26488,1,3,0)
 ;;=3^Borderline Intellectual Functioning
 ;;^UTILITY(U,$J,358.3,26488,1,4,0)
 ;;=4^R41.83
 ;;^UTILITY(U,$J,358.3,26488,2)
 ;;=^5019442
 ;;^UTILITY(U,$J,358.3,26489,0)
 ;;=Z56.82^^100^1275^4
 ;;^UTILITY(U,$J,358.3,26489,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26489,1,3,0)
 ;;=3^Military Deployment Status,Current
